Skip to main content
A person writing in a notebook.

Real Stories from the Cholangiocarcinoma Community

Being diagnosed with cholangiocarcinoma (CCA) can be overwhelming. That's why it is important to have the right support and information.

Here you will find helpful CCA patient education tools and resources.

A person writing in a notebook.

Patient Stories

A photograph of Robin.

Robin’s Story

A photograph of Robin.
“The information from biomarker testing has been an important part in helping to determine my care plan moving forward.”

Find out about Robin’s experience with CCA, including her diagnosis and how biomarker testing fit in with her care plan.

I’m 67 years old, and I’ve been married for 38 years. I’m a psychologist who worked in private practice, and I have two daughters who live across the country. I also have one grandson and another one on the way.

I started having symptoms in June of 2017. It almost felt like a gallbladder attack; the pain was intense, and then it was gone. I went to the emergency room, and following a CT scan and some lab work, they originally thought it was gastrointestinal. However, I knew I had a family history of liver disease and was being observed for cysts on my liver.

At first, CT scans didn’t show anything, which was frustrating. However, after about 10 or 11 months and additional testing, a tumor was discovered in my liver. Because of the tumor’s location in my liver, my oncologist decided to remove the whole tumor surgically rather than just taking a sample for a biopsy. After testing of a sample of the tumor, I was diagnosed with cholangiocarcinoma. I was shocked; I had convinced myself that it can’t be cancer.

When I was first diagnosed, I knew nothing about cholangiocarcinoma. I relied on my oncologist for a lot of information, and I tried doing some of my own research. It was hard; there was a lot of information to sift through, and some of it was really scary.

Fortunately, they had sent a sample of my tumor for biomarker testing. I learned a lot about biomarker testing from attending various conferences and webinars held by the Cholangiocarcinoma Foundation. The biomarker testing showed that my tumor had a type of mutation called an FGFR2 fusion. The information from biomarker testing has been an important part in helping to determine my care plan moving forward.

My advice to other people who have cholangiocarcinoma considering biomarker testing is that knowledge is power. Learning more about your cancer may cause some anxiety, but it can be really empowering too.

The results showed that my tumor had a type of mutation called FGFR2 fusion. The information from biomarker testing has been an important part in helping to determine my care plan moving forward.
The results showed that my tumor had a type of mutation called FGFR2 fusion. The information from biomarker testing has been an important part in helping to determine my care plan moving forward.

This site is for US residents 18 years of age or older. The information on this website is not a substitute for a visit or a consultation with a Healthcare Professional. Remember that a Healthcare Professional is the single best source of medical advice regarding your health. Please consult a Healthcare Professional if you have any questions.

By clicking third-party links, you are leaving an Incyte website and going to an external, entirely independent third-party website. Incyte provides these links as a service to its website visitors and users and takes no responsibility for any information presented on such sites or for your use of or access to such sites.